A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia
Status:
Completed
Trial end date:
2019-07-26
Target enrollment:
Participant gender:
Summary
This is a 4-visit, multi-center, randomized, double-masked, parallel group study evaluating
the safety and efficacy of CSF-1 in the treatment of presbyopia.